Drug Search Results
More Filters [+]

RD047-26

Alternative Names: rd047-26, rd04726, rd047 26
Latest Update: 2012-05-30
Latest Update Note: Clinical Trial Update

Product Description

for the treatment of mild to moderate atopic dermatitis with associated pruritus in adults

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Device

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Oculus Innovative Sciences
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for RD047-26

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Dermatitis, Atopic|Pruritus

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

MIC-AD-001

P2

Completed

Dermatitis, Atopic|Pruritus

2010-12-01

Recent News Events

Date

Type

Title